• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质结合型尿毒症毒素在血液透析患者外周动脉疾病和血管通路失败中的作用。

The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis.

机构信息

Division of Nephrology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan, ROC.

出版信息

Atherosclerosis. 2012 Nov;225(1):173-9. doi: 10.1016/j.atherosclerosis.2012.07.012. Epub 2012 Aug 28.

DOI:10.1016/j.atherosclerosis.2012.07.012
PMID:22981405
Abstract

OBJECTIVE

p-Cresyl sulfate (PCS) and indoxyl sulfate (IS) have been reported to predict poor clinical outcomes in hemodialysis (HD) patients. However, little is known about the effect of the two toxins on peripheral arterial disease (PAD) and vascular access dysfunction. Our objective was to explore the association between the two toxins and PAD and vascular access failure (VAF) in a hemodialysis-based cohort.

METHODS

We enrolled 100 stable and eligible HD patients from a single medical center. These patients were screened for PAD by machine and recorded as ABI (ankle brachial index) and brachial-ankle PWV (pulse wave velocity). Serum levels of PCS, IS and biochemical data were also collected concurrently. In addition, we also recorded the first event of VAF and frequency of PTA and thrombectomy during 3-year follow-up.

RESULTS

Total and free PCS were correlated to right and left ABI and PWV (p < 0.01), and total IS was associated with right and left ABI (p < 0.01) by Pearson's analysis. Repeated measuring by mixed model analysis revealed that serum albumin (p = 0.003), cholesterol (p = 0.01) and total PCS (p = 0.031) had significant correlation with ABI after adjusting other confounding factors. As for brachial-ankle PWV, serum triglyceride (p = 0.002), total IS (p = 0.04) and total PCS (p = 0.050) reached significance finally. In addition, multivariate Cox regression analysis revealed dialysis length and total PCS were related to AV-shunt failure event (Hazard Ratio: 1.14, p = 0.01, and Hazard Ratio: 1.04, p = 0.04, respectively). Both of total and free PCS and IS were also positively linked to numbers of PTA and thrombectomy. Further, the Kaplan-Meier analysis showed only total PCS was significantly associated with vascular access failure event (log rank P = 0.02).

CONCLUSION

This study shows that the serum levels of PCS and IS were associated with PAD and total PCS could be a valuable determinant of access viability other than traditional or nontraditional risk factors in HD patients.

摘要

目的

对甲酚硫酸酯(PCS)和吲哚硫酸酯(IS)已被报道可预测血液透析(HD)患者的不良临床结局。然而,关于这两种毒素对周围动脉疾病(PAD)和血管通路功能障碍的影响知之甚少。我们的目的是在基于血液透析的队列中探讨这两种毒素与 PAD 和血管通路失败(VAF)之间的关系。

方法

我们从一家医疗中心招募了 100 名稳定且符合条件的 HD 患者。这些患者通过机器筛查 PAD,并记录踝肱指数(ABI)和臂踝脉搏波速度(baPWV)。同时收集血清 PCS、IS 水平和生化数据。此外,我们还记录了 3 年随访期间的 VAF 首次事件和 PTA 及血栓切除术的频率。

结果

总 PCS 和游离 PCS 与右、左 ABI 和 PWV 呈正相关(p<0.01),而总 IS 与右、左 ABI 呈正相关(p<0.01),这是通过 Pearson 分析得出的。通过混合模型分析的重复测量发现,血清白蛋白(p=0.003)、胆固醇(p=0.01)和总 PCS(p=0.031)在调整其他混杂因素后与 ABI 显著相关。对于臂踝 PWV,血清甘油三酯(p=0.002)、总 IS(p=0.04)和总 PCS(p=0.050)最终具有统计学意义。此外,多变量 Cox 回归分析显示透析时间和总 PCS 与动静脉分流失败事件相关(危险比:1.14,p=0.01,和危险比:1.04,p=0.04)。总 PCS 和游离 PCS 以及 IS 均与 PTA 和血栓切除术的次数呈正相关。此外,Kaplan-Meier 分析表明只有总 PCS 与血管通路失败事件显著相关(对数秩 P=0.02)。

结论

本研究表明,PCS 和 IS 的血清水平与 PAD 相关,总 PCS 可能是 HD 患者血管通路存活的一个有价值的决定因素,而不仅仅是传统或非传统危险因素。

相似文献

1
The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis.蛋白质结合型尿毒症毒素在血液透析患者外周动脉疾病和血管通路失败中的作用。
Atherosclerosis. 2012 Nov;225(1):173-9. doi: 10.1016/j.atherosclerosis.2012.07.012. Epub 2012 Aug 28.
2
Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.腹膜透析患者胃肠道相关尿毒症毒素:一项 5 年随访的初步研究。
Arch Med Res. 2013 Oct;44(7):535-41. doi: 10.1016/j.arcmed.2013.09.007. Epub 2013 Sep 19.
3
Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis.在长期血液透析患者中,与晚期糖基化终产物相关的是硫酸吲哚酚,而非对甲酚硫酸酯。
Kidney Blood Press Res. 2015;40(2):121-9. doi: 10.1159/000368488. Epub 2015 Mar 19.
4
Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.慢性肾脏病范围内的尿毒症毒素与心血管疾病:一项观察性研究
Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):1035-42. doi: 10.1016/j.numecd.2014.04.006. Epub 2014 May 4.
5
Free p-cresol sulfate is associated with survival and function of vascular access in chronic hemodialysis patients.游离对甲酚硫酸盐与慢性血液透析患者血管通路的生存和功能相关。
Kidney Blood Press Res. 2012;35(6):583-8. doi: 10.1159/000339709. Epub 2012 Aug 21.
6
Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.对慢性肾衰竭患者中对甲酚硫酸盐(PCS)和硫酸吲哚酚(IS)与心血管事件及全因死亡率之间关联的荟萃分析。
PLoS One. 2015 Jul 14;10(7):e0132589. doi: 10.1371/journal.pone.0132589. eCollection 2015.
7
Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.对甲酚硫酸酯水平升高与心力衰竭患者的不良预后独立相关。
Heart Vessels. 2016 Jul;31(7):1100-8. doi: 10.1007/s00380-015-0702-0. Epub 2015 Jul 2.
8
Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.维持性血液透析的慢性肾脏病患者尿毒症毒素与抑郁的关系。
Gen Hosp Psychiatry. 2013 Jan-Feb;35(1):23-7. doi: 10.1016/j.genhosppsych.2012.08.009. Epub 2012 Oct 6.
9
Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study.血清游离对甲酚硫酸盐水平可预测老年血液透析患者的心血管和全因死亡率——一项前瞻性队列研究。
Nephrol Dial Transplant. 2012 Mar;27(3):1169-75. doi: 10.1093/ndt/gfr453. Epub 2011 Sep 2.
10
Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.使用结合竞争剂去除血液透析中的蛋白结合型尿毒症毒素。
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):394-402. doi: 10.2215/CJN.05240418. Epub 2019 Feb 12.

引用本文的文献

1
Gut-derived uremic toxins and cardiovascular health in chronic kidney disease.慢性肾脏病中肠道源性尿毒症毒素与心血管健康
Tzu Chi Med J. 2025 Apr 11;37(3):264-274. doi: 10.4103/tcmj.tcmj_293_24. eCollection 2025 Jul-Sep.
2
Clinical management of peripheral arterial disease in chronic kidney disease-a comprehensive review from the European Renal Association CKD-MBD Working Group.慢性肾脏病患者外周动脉疾病的临床管理——欧洲肾脏协会慢性肾脏病-矿物质与骨异常工作组的全面综述
Clin Kidney J. 2025 Apr 7;18(5):sfaf089. doi: 10.1093/ckj/sfaf089. eCollection 2025 May.
3
Serum -Cresyl Sulfate Levels Correlate with Peripheral Arterial Disease in Hypertensive Patients.
血清对甲酚硫酸盐水平与高血压患者外周动脉疾病相关。
Diagnostics (Basel). 2025 Apr 25;15(9):1097. doi: 10.3390/diagnostics15091097.
4
The Effect of Synbiotic Supplementation on Uremic Toxins, Oxidative Stress, and Inflammation in Hemodialysis Patients-Results of an Uncontrolled Prospective Single-Arm Study.共生元补充对血液透析患者尿毒症毒素、氧化应激和炎症的影响-一项非对照前瞻性单臂研究的结果。
Medicina (Kaunas). 2023 Jul 28;59(8):1383. doi: 10.3390/medicina59081383.
5
Improving the In Vitro Removal of Indoxyl Sulfate and p-Cresyl Sulfate by Coating Diatomaceous Earth (DE) and Poly-vinyl-pyrrolidone-co-styrene (PVP-co-S) with Polydopamine.用聚多巴胺对硅藻土(DE)和聚-乙烯基-吡咯烷酮-共-苯乙烯(PVP-co-S)进行包被,以提高其对硫酸吲哚酚和对甲酚硫酸盐的体外去除率。
Toxins (Basel). 2022 Dec 8;14(12):864. doi: 10.3390/toxins14120864.
6
Gut microbiota in sarcopenia and heart failure.肌肉减少症和心力衰竭中的肠道微生物群。
J Cardiovasc Aging. 2022 Jul;2(3). doi: 10.20517/jca.2022.07. Epub 2022 Jul 5.
7
Serum -Cresyl Sulfate Level Is an Independent Marker of Peripheral Arterial Stiffness as Assessed Using Brachial-Ankle Pulse Wave Velocity in Patients with Non-Dialysis Chronic Kidney Disease Stage 3 to 5.血清硫酸对甲酚水平是评估非透析慢性肾脏病 3 至 5 期患者肱踝脉搏波速度的外周动脉僵硬度的独立标志物。
Toxins (Basel). 2022 Apr 16;14(4):287. doi: 10.3390/toxins14040287.
8
Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?尿毒症毒素与慢性肾脏病心血管风险:除了过去的发现,我们最近又有了哪些新的认识?
Toxins (Basel). 2022 Apr 14;14(4):280. doi: 10.3390/toxins14040280.
9
Recent trends in therapeutic application of engineered blood purification materials for kidney disease.用于肾病的工程化血液净化材料的治疗应用的最新趋势。
Biomater Res. 2022 Feb 4;26(1):5. doi: 10.1186/s40824-022-00250-0.
10
The Impact of CKD on Uremic Toxins and Gut Microbiota.慢性肾脏病对尿毒症毒素和肠道微生物群的影响。
Toxins (Basel). 2021 Mar 31;13(4):252. doi: 10.3390/toxins13040252.